Skip to main content
. Author manuscript; available in PMC: 2011 Sep 22.
Published in final edited form as: J Proteomics. 2011 Apr 23;74(7):1002–1014. doi: 10.1016/j.jprot.2011.04.013

Fig. 1.

Fig. 1

A) Histology-directed MALDI IMS. Cellular regions are selected by a pathologist to ensure melanoma foci are targeted. B) The MALDI spectra from these regions were averaged and compared by SAM (control LN versus tumor-positive LN) and by CPH to determine proteins associated with survival and recurrence.